Antithrombotic Therapy for VTE Disease
Top Cited Papers
- 1 February 2016
- journal article
- research article
- Published by Elsevier BV in Chest
- Vol. 149 (2), 315-352
- https://doi.org/10.1016/j.chest.2015.11.026
Abstract
No abstract availableKeywords
Funding Information
- American College of Chest Physicians
This publication has 231 references indexed in Scilit:
- Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT studyBMJ Open, 2013
- Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolismMultidisciplinary Respiratory Medicine, 2013
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendationsJournal of Clinical Epidemiology, 2013
- Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesThrombosis Journal, 2013
- Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest, 2012
- Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- A New Risk Scheme to Predict Warfarin-Associated HemorrhageJournal of the American College of Cardiology, 2011
- The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysisCritical Care, 2011
- Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trialBMJ, 2007